{"id":522546,"date":"2021-08-03T16:20:45","date_gmt":"2021-08-03T20:20:45","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/healthcare-trust-of-america-inc-announces-leadership-transition\/"},"modified":"2021-08-03T16:20:45","modified_gmt":"2021-08-03T20:20:45","slug":"healthcare-trust-of-america-inc-announces-leadership-transition","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/healthcare-trust-of-america-inc-announces-leadership-transition\/","title":{"rendered":"Healthcare Trust of America, Inc. Announces Leadership Transition"},"content":{"rendered":"
\n

Director Peter N. Foss Named Interim President and CEO<\/h2>\n

Lead Independent Director W. Bradley Blair, II Elected as Chairman of the Board<\/h2>\n

Scott D. Peters Resigns as Chairman of the Board, President and CEO<\/h2>\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n SCOTTSDALE, Ariz.<\/span>, Aug. 3, 2021<\/span> \/PRNewswire\/ —\u00a0Healthcare Trust of America, Inc. (the “Company”) (NYSE: HTA) today announced that its Board of Directors has named one of its independent directors, Peter N. Foss<\/span>, as Interim President and Chief Executive Officer, effective August 2<\/span>, 2021.\u00a0 Scott D. Peters<\/span> resigned effective August 2, 2021<\/span> as a director, Chairman of the Board, President and Chief Executive Officer of the Company.\u00a0 Effective August 2, 2021<\/span>, the Lead Independent Director of the Board, W. Bradley Blair, II<\/span>, was elected to be Chairman of the Board. Mr. Foss has stepped down as a member of the Audit, Compensation and Nominating and Corporate Governance Committees of the Board, but has remained a member of the Board’s Investment Committee.\u00a0 Warren D. Fix<\/span>, an independent director currently serving on the Board, has replaced Mr. Foss as Chairman of the Board’s Compensation Committee.<\/p>\n

\n

\n
\n \"Healthcare
\n <\/a>\n <\/p>\n<\/p><\/div>\n

“Peter has been on HTA’s board since April 2015<\/span> and is well-versed in the Company’s strategy and has deep experience in the healthcare industry,” Blair said. “He has been involved in numerous Board committees and he, along with the strong management team, are well positioned to guide HTA through this transition.”<\/p>\n

\n About Peter N. Foss<\/span><\/b>\n <\/p>\n

\n Peter Foss<\/span> has served as an independent director of the Company since April 2015<\/span>. He provides the Company strong leadership skills through significant experience in customer relationships and stakeholder and employee engagement.\u00a0 He is a 35 year veteran of General Electric Company (“GE”) where he was President of GE’s Olympic Sponsorship and Corporate Accounts from 2003 until his retirement in February 2013<\/span>. In addition, Mr. Foss directed the Corporate Sales Program at GE. Mr. Foss was rehired by GE in November 2013<\/span> to serve as the leader of the GE\/NFL Brain Research Program. Prior to his most recent positions, he served for six years as the President of GE Polymerland, a commercial organization representing GE Plastics in the global marketplace. Prior to GE Polymerland, Mr. Foss served in various commercial roles with GE, including introducing LEXAN\u00ae film in the 1970s, and was the Market Development Manager on the ULTEM\u00ae introduction team in 1982. He has also served as the Regional General Manager for four of the GE Plastics regions, including leading the GE Plastics effort in Mexico<\/span> in the mid-1990s.\u00a0 Mr. Foss serves on the board of Savista (formerly nThrive), a private company. Mr. Foss previously served on the board of directors of First Horizon National Corporation, Capital Bank Corp., Green Bankshares and TIB Financial Corp. <\/p>\n

\n About W. Bradley Blair, II<\/span><\/b>\n <\/p>\n

Mr. Blair was appointed as the lead independent director of the Company’s Board of Directors in December 2014<\/span> and has served as an independent director of the Company since September 2006<\/span>. Mr. Blair served as the Chief Executive Officer, President and Chairman of the board of directors of Golf Trust of America, Inc. (now known as Pernix Therapeutics Holdings, Inc.) from the time of its formation as a REIT and initial public offering in 1997 until his resignation and retirement in November 2007<\/span>. During that term, Mr. Blair managed the acquisition, operation, leasing and disposition of the assets of the portfolio. From 1993 until February 1997<\/span>, Mr. Blair served as Executive Vice President, Chief Operating Officer and General Counsel for The Legends Group. As an officer of The Legends Group, Mr. Blair was responsible for all aspects of its operations, including acquisitions, development and marketing. From 1978 to 1993, Mr. Blair was the managing partner at Blair Conaway Bograd & Martin, P.A., a law firm specializing in real estate, finance, taxation and acquisitions.<\/p>\n

\n About HTA<\/b>\n <\/p>\n

Healthcare Trust of America, Inc. (NYSE: HTA) is the largest dedicated owner and operator of medical office buildings in the United States<\/span>, with assets comprising approximately 25.6 million square feet of GLA, with $7.5 billion<\/span> invested primarily in medical office buildings as of March 31<\/span>, 2021.\u00a0 HTA provides real estate infrastructure for the integrated delivery of healthcare services in highly-desirable locations.\u00a0 Investments are targeted to build critical mass in 20 to 25 leading gateway markets that generally have leading university and medical institutions, which translates to superior demographics, high-quality graduates, intellectual talent and job growth.\u00a0 The strategic markets HTA invests in support a strong, long-term demand for quality medical office space.\u00a0 HTA utilizes an integrated asset management platform consisting of on-site leasing, property management, engineering and building services, and development capabilities to create complete, state of the art facilities in each market.\u00a0 We believe this drives efficiencies, strong tenant and health system relationships, and strategic partnerships that result in high levels of tenant retention, rental growth and long-term value creation.\u00a0 Headquartered in Scottsdale, Arizona<\/span>, HTA has developed a national brand with dedicated relationships at the local level. <\/p>\n

Founded in 2006 and listed on the New York Stock Exchange in 2012, HTA has produced attractive returns for its stockholders that have outperformed the US REIT index.\u00a0 More information about HTA can be found on the Company’s Website (www.htareit.com<\/a>), Facebook, LinkedIn, Instagram and Twitter. <\/p>\n

\n Forward-Looking Language<\/b>\n <\/p>\n

This press release contains certain forward-looking statements.\u00a0 Forward-looking statements are based on current expectations, plans, estimates, assumptions and beliefs, including expectations, plans, estimates, assumptions and beliefs about HTA, stockholder value and earnings growth.<\/p>\n

The forward-looking statements included in this press release are subject to numerous risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements.\u00a0 Assumptions relating to the foregoing involve judgments with respect to, among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond HTA’s control.\u00a0 Although HTA believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions, HTA’s actual results and performance could differ materially and in adverse ways from those set forth in the forward-looking statements.\u00a0 Factors which could have a material adverse effect on HTA’s operations and future prospects include, but are not limited to:<\/p>\n